Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case!
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Torrent Pharmaceuticals Limited Anagrelide Capsule USP 1mg - recalled due to dissolution test failure, USA

3 years ago

United States

Company name: Torrent Pharmaceuticals Limited
Brand name: Torrent Pharmaceuticals Limited
Product recalled: Anagrelide Capsule USP 1mg
Reason of the recall: Due to dissolution test failure
FDA Recall date: December 09, 2020
Recall details: Torrent Pharmaceuticals Limited is voluntarily recalling one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing. Failed dissolution can result in a slower rate and extent of drug release leading to less anagrelide available in the body. For seriously ill patients with elevated platelet counts, less available anagrelide could increase the risk of clotting (blood coagulation) and clotting or bleeding events such as a heart attack or stroke which could be life-threatening.

To date, Torrent Pharmaceuticals Limited has not received any reports of adverse events related to this recall. Anagrelide is used to treat a blood cell disorder called thrombocythemia (also called thrombocytosis), which occurs when your body produces too many platelet cells. As the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment, patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.  The product subjected to the recall is listed below and packaged in bottles. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing the product.

- Anagrelide Capsule USP 1mg,100-count bottles. NDC: 13668-462-01. Lot/Batch: BFD1G001. Expiration Date: 12/2021

Anagrelide Capsules, USP were distributed nationwide to Torrent’s wholesale distributor and retail customers. Torrent Pharmaceuticals Limited is notifying its distributors and customers by phone and in writing to immediately discontinue distribution of the specific lots being recalled and to notify their sub-accounts. Torrent is arranging for return of all recalled products to Qualanex. Instructions for returning recalled products are given in the recall letter.

Consumers with medical questions regarding this recall or to report an adverse event can contact Torrent Pharmaceuticals Limited at 1-800-912-9561 (live calls received 8:00 am – 5:00 pm Eastern Time (Monday-Friday), voicemail available 8:00 am – 5:00 pm Eastern Time (Monday-Friday).

Consumers should also contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Any general questions regarding the return of this product should be directed to Qualanex at 1-888-424-4340 (live calls received 8 am - 5:00 pm Eastern Time, Monday-Friday).

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Check the full recall details on fda.gov

Source: FDA

303


Related Reports

Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can... See More result in an over-potent dosing regimen. The affected Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL lots were distributed Nationwide in the USA directly to Wholesalers and Distributors. The Lots were distributed between 11/09/2023 and 2/20/2024. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall.

Risk Statement: Adult patients who are prescribed the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, may receive up to 4 grams of oral vancomycin per day because of the overfilled bottle. Some patients with inflammatory disorders of the intestinal mucosa also may have significant systemic absorption of vancomycin. These patients may be at risk for the development of adverse reactions associated with higher doses of vancomycin oral solution. Worsening renal function could be associated with electrolyte abnormalities such as high potassium leading to cardiac arrest.

The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.

Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL, is administered orally for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic- associated pseudomembranous colitis caused by C. difficile.

The Vancomycin HCl for Oral Solution, USP, 250 mg/5mL subject to the recall, are identified by the NDC numbers stated on the product label. The following lot numbers of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL are included in this recall.

Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL.
- Pack Size: 80 mL, Expiration Date: 09/2025, Lot: 22613003A, NDC No.: 69238-2261-3.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613004A, NDC No.: 69238-2261-7.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613005A, NDC No.: 69238-2261-7.
- Pack Size: 300 mL, Expiration Date: 09/2025, Lot: 22613005B, NDC No.: 69238-2261-5.

Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Retailers who have Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL, which are being recalled, should examine their inventory and cease dispensing any of the impacted lots.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Amneal Pharmaceuticals, LLC.
Brand name: Amneal
Product recalled: Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL
Reason of the recall: Super potent due to bottles being overfilled
FDA Recall date: March 27, 2024

Source: fda.gov
See Less


Pyramid Wholesale is issuing a recall of various brands of products sold as dietary supplements for sexual enhancement because they contain undeclared prescription drugs including Sildenafil (Viagra) and/or Tadalafil (Cialis). There have been no reports of injury or illness, to date. They were sold in bulk to... See More other distributors and retailers in California and out of state.

These products have the potential to cause severe adverse health effects due to misuse, overuse, interaction with other medications, underlying health conditions, and overall lack of oversight or consultation with medical professionals.

The products were distributed under 11 different brand names and varied in product form and size. A full list is available in the link below. Consumers should immediately discontinue use of the product.

Company name: Pyramid Wholesale
Brand name: Various
Product recalled: Dietary supplements for sexual enhancement
Reason of the recall: Undeclared Sildenafil and/or Tadalafil
FDA Recall date: March 20, 2024

Source: fda.gov
See Less
288


Several brands of folic acid tablets have been recalled in Canada due to concerns that affected lots may exceed the acceptable intake limit for N-nitroso-folic acid. The recall involves multiple brands distributed across the country.

-Affected products
Brand: Compliments FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG,... See More Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115NHH
Brand: Equate FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115LRJ & 2G3115NHF
Brand: Health One FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115NJL
Brand: Nature's Bounty FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2340T8130A
Brand: Pharmasave FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115NHG
Brand: Sisu FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115M1C

Consumers are advised to consult their healthcare provider if they have any health concerns related to this recall.

Return affected product to your local pharmacy or place of purchase. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

If you or a loved one are harmed or experiencing any symptoms, it is important to report it. Reporting can help to detect & resolve outbreaks early and prevent others from being harmed, and enables better surveillance. If symptoms persist, seek medical care.

Source: recalls-rappels.canada.ca
See Less
84


Central Valley Ag Cooperative has voluntarily recalled its GS Hamster/Gerbil + Turmeric food due to a potential Salmonella contamination. The recall affects both animals and humans and is currently ongoing. The recalled product has been distributed in Kansas.

The recalled product is GS Hamster/Gerbil + Turmeric, sold... See More in bulk super sacks. A total of 7,464 pounds of the product, bearing the lot number B0624179808 11399 OXBOW and a best before date of 2/6/2026, have been recalled.

The recall was initiated after an ingredient in the gerbil/hamster feed tested positive for Salmonella.

The issue was discovered during routine testing by the company. The recall was initiated on February 26, 2024.

In case you are experiencing Salmonella symptoms such as diarrhea, abdominal cramps, and fever, it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Source: accessdata.fda.gov
See Less


Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulates in the product... See More solution. The lot was distributed nationwide to wholesalers and hospitals from June 16, 2022, through October 17, 2022. To date, Par has not received any reports of adverse events related to this recall.

Administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material. If the particulate matter reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs, or brain which can cause stroke and even lead to death.

Treprostinil Injection is formulated for subcutaneous or intravenous infusion. The product is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise and for patients who require a transition from epoprostenol to reduce the rate of clinical deterioration.

Treprostinil Injection 20mg/20mL (1mg/mL) is distributed in 20mL multidose vials as sterile solutions in water for injection, individually packaged in cartons under NDC #42023-206-01. Only Lot 57014, expiration date 04/2024 is affected by this recall. Vials from the affected lot bear the attached label.

Par is providing written notification to wholesale accounts and the hospital location that has received the affected lot and is arranging for the return of all existing inventory of Lot 57014 through Inmar, Inc. Wholesale distributors and hospital pharmacies that have the product being recalled should immediately discontinue the use and stop distribution immediately.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Endo International, Par Pharmaceutical
Brand name: Par Pharmaceutical
Product recalled: Treprostinil 20mg/20mL Injection
Reason for the recall: Potential Presence of Silicone Particulate Matter
FDA Recall date: March 12, 2024

Source: fda.gov
See Less
303


Colorado Springs Utilities reported about 1,199 customers without electricity in downtown Colorado Springs on Thursday afternoon, Mar 28. The outage started at 3:57 p.m. The estimated time for restoration was listed at 7:47 p.m. The cause of the outage was not determined. Power has been already restored... See More to the area.

Outage link: s3.amazonaws.com
Source: csu.org
Published: 2024-03-28
See Less


A precautionary boil water advisory has been issued for customers who get drinking water from the Runnelstown Utility District, located in Perry County. The notice will affect customers on Hinton Loop, Conway Road, and Pumping Station Road.

Source: wdam.com
Published: 2024-03-28 See Less


JXN Water has issued multiple boil water alerts around the city of Jackson. At least 484 connections are impacted. The streets under the boil water alert are as follows: W. Silas Street, S. Gallatin Street, Union Street, Summer Street, Eddy Street, Cameron Street, Nichols Boulevard, Winfield Street,... See More Savanna Street, Creston Avenue, Veld Drive, Fleming Road, Hines Avenue, Gretchen Street, Avalon Road, Belvedere Road, Wellington Road, Robinhood Road, Broadmoor Drive, Churchill Drive, Cedarhurst Drive, Londonderry Drive, E. Northside Drive, Windy Hill Cove, Spring Valley Drive, Springridge Road, Whiting Road, Dixie Drive, Van Winkle Park Drive, John R Lynch Street and President Street.

Source: wapt.com
Published: 2024-03-28
See Less


The Walnut Bayou Water System issued a boil advisory on March 28, 2024, for areas in Tallulah, La., effective immediately. The affected areas are 772 – 2260 Hwy 80 West, 335 Gregory Rd, Butts Dr, 126 Cox Rd, 149 Hilderbrand Rd, Eldorado Plantation Dr, Averett Rd, 317... See More Fred Morgan Rd, 123 Lance Morgan Rd, Quebec Rd, 108 – 377 West Bear Lake Rd, Bedgood Rd.

Source: myarklamiss.com
Published: 2024-03-28
See Less


The Boil Water advisory issued for customers in the city of Cannon Beach has been removed, according to officials.

Source: cannonbeachgazette.com
Published: 2024-03-28 See Less


Recent Interesting Reports

I received 1 bottle containing 1oz of powder (did not open bottle)with a ship date of 3/5 and 1 bottle shipped 3/11 that I did not order. Called phone number 800-609-4174. Female answered phone but said she only speaks Spanish and she hung up. Immediately called back.... See More She answered and I gave her my name & address and again she hung up. Immediately placed call #3 and inquired if anyone at her site spoke English ' again she hung up. I made one more call and left my phone number ' again another hang up. In process of reviewing all credit card charges. Tampa, FL, USA

2 pkgs. of 1 bottle each, Subgenix containing 1oz powder -(did not remove shrink wrap from bottle)did not order sent by Fullfillment House
See Less
522


I received a phishing email claiming to be “Malwarebytes” offering me a 3 year subscription that a) doesn’t exist and b) I never bought, and attempted to charge me over $400 including tax.

The phishing email had the phone number: 888 889-2916, which is not Malwarebytes’s official... See More support number.

The originating email does not have malwarebytes. com, the phone number is incorrect, and I never purchased malwarebytes premium. The actual malwarebytes offering is called “plus” and not “premium”, and malwarebytes does not offer a 3 year plan option, only monthly, annually, and 2 year. Even if malwarebytes did offer a 3 year plan, the total would come out to roughly $297 and not $399, since the annual option is priced at 99.99 on Malwarebytes’s website.

Per malwarebytes’s official website, renewal emails come from the following addresses, and none of them are present:
no-reply@ store-mail.malwarebytes. com
no-reply@ mail.malwarebytes. com
noreply@ e.malwarebytes. com
noreply@ t.malwarebytes. com

I already alerted both Malwarebytes and relevant regulators (FTC, FBI).
See Less
168


I also receive today a package whitout being ask whith Black wireless headphone and White earplug headphone. What can I do? I dont need this!

Return DI RETURN ONLY, NOT FOR SALES Postlink Am Eifeltor 501, 50997 Köln, Germany See Less


I received a package today, March 25, 2024 that I did not order. The package contains 2 bars of orange soap. There's no lable or anything attached. I looked up the address from where it was shipped from in California. It's a warehouse called Cambria that is... See More no longer in operation. The building is up for sale. See Less
233


I received a package yesterday that I had not ordered. Unfortunately, I happened to be informed that I still have two more parcels, I was not even at the address, a friend received it, so I did not notice the deception until today. 220 lei lost. See Less


I am reporting a package I received but did not order. It is verti bio. I don’t know how they got my name and address. It’s for weight loss and energy See Less
37


I came home today from work got my mail and there was a package in it from a Heather's Motty. Inside were 4 Blue disks. I do NOT know who this person is and I NEVER ordered these. PLEASE help me out with this cuz I do NOT want to get charged for something I did NOT order. See Less
80


Last 30 days